HEUKING advises Aachen-based BioTech start-up BioThrust on its pre-seed extension financing round
Aachen-based BioTech start-up BioThrust has successfully completed a pre-seed extension financing round. The start-up intends to use the raised capital to advance pilot studies for the further development of its ComfyCell bioreactor platform. The platform is designed to help accelerate the commercialization of cell and gene therapies, the widespread availability of which has been limited by high production costs and long innovation cycles.
In addition to existing shareholders RWTH Aachen and Freigeist, new investors ALAGO, NRW.BANK, and Theo Bongartz participated in the financing round. The round was also supported by several business angels.
A Düsseldorf-based HEUKING team led by Dr. Patrick Müller, LL.M., Ilona Schütz, and Laura Jochem, LL.M., provided legal advice to BioThrust on the structuring and execution of the financing round. The team regularly advises start-ups and VC investors in various VC financing rounds.
Counsel to BioThrust
HEUKING:
Dr. Patrick Müller, LL.M. (University of the West of England, Bristol) (lead),
Ilona Schütz,
Laura Jochem, LL.M. (all Venture Capital), all Düsseldorf
